Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 48Lymphoid 46Myeloid 34Plasma cell 33Sarcoma 30Dermatologic 20Classical hematology 16Genitourinary 5Other neoplasm 4CNS 3Head & Neck 2Breast 2Thoracic 1Gynecologic 1

Conditions

Ovarian Neoplasms 14Uterine Cervical Neoplasms 6Breast Neoplasms 5Melanoma 4Fallopian Tube Neoplasms 4Carcinoma, Ovarian Epithelial 4Vaginal Neoplasms 3Neoplasm Metastasis 3Esophageal Neoplasms 3Stomach Neoplasms 2Penile Neoplasms 2Papillomavirus Infections 2Pancreatic Neoplasms 2Oropharyngeal Neoplasms 2Lung Neoplasms 2Kidney Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Anus Neoplasms 2Vulvar Neoplasms 1Vulvar Diseases 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma, Synovial 1Recurrence 1Rectal Neoplasms 1Neoplasms 1Mesothelioma 1

Interventions

Carboplatin 19Paclitaxel 17Cisplatin 9Cyclophosphamide 8Gemcitabine 7Bevacizumab 6Topotecan 5pembrolizumab 4olaparib 4liposomal doxorubicin 4durvalumab 4Letrozole 4Interleukin-2 4Drug Therapy 4Doxorubicin 4Albumin-Bound Paclitaxel 4rucaparib 3fludarabine 3chiauranib 3cemiplimab 3camrelizumab 3Therapeutics 3Itraconazole 3Injections 3Hyperthermic Intraperitoneal Chemotherapy 3Everolimus 3pazopanib 2iniparib 2eprenetapopt 2avelumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recurrence × fludarabine phosphate × Gynecologic × Clear all
NCT06305299 2026-05-19

Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells

UNC Lineberger Comprehensive Cancer Center

Phase 1 Recruiting
27 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡